Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan in HeartMate 3 LVAD recipients
2019-003888-22Phase 4Completed
- Sponsor
- University of Zagreb School of Medicine
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in heart failure (HF) and hypertension (HTN) comparing Sacubitril/valsartan with Standard of care for blood pressure treatment (2 arms). Started Nov 2020; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)hypertension (HTN)
Beyond the preview
Go deeper on 2019-003888-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003888-22.